Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts

Background/Aims: The malignant biological behavior of gastric cancer(GC) is not only determined by cancer cells alone, but also closely regulated by the microenvironment. Fibroblasts represent a large proportion of the components in the tumor microenvironment, and they promote the development of disease. Currently, accumulating evidence suggests that exosomes can function as intercellular transport systems to relay their contents, especially microRNAs(miRNAs). Methods: First, we detected the highly-expressed level of miR-27a in exosomes isolated from gastric cancer cells by qRT-PCR. MiR-27a –over-expressed models in vitro and in vivo were established to investigate the transformation of cancer-associated fibroblasts observed by Western blotting, and the malignant behavior of gastric cancer cells using the methods CCK8 and Transwell. Moreover, the downregulation of CSRP2 in fibroblasts was used to evaluate the promotion of malignancy of gastric cancer using the methods CCK8 and Transwell. Results: In this study, we found a marked high level of miR-27a in exosomes derived from GC cells. miR-27a was found to function an oncogene that not only induced the reprogramming of fibroblasts into cancer-associated fibroblasts(CAFs), but also promoted the proliferation, motility and metastasis of cancer cells in vitro and in vivo. Conversely, CAFs with over-expression of miR-27a could pleiotropically increase the malignant behavior of the GC cells. For the first time, we revealed that CSRP2 is a downstream target of miR-27a. CSRP2 downregulation could increase the proliferation and motility of GC cells. Conclusion: Thus, this report indicates that miR-27a in exosomes derived from GC cells has a crucial impact on the microenvironment and may be used as a potential therapeutic target in the treatment of GC

[1]  Jin-hai Tang,et al.  Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer , 2017, Cellular Physiology and Biochemistry.

[2]  Xu Wang,et al.  Exosomes Derived from Human Bone Marrow Mesenchymal Stem Cells Promote Tumor Growth Through Hedgehog Signaling Pathway , 2017, Cellular Physiology and Biochemistry.

[3]  R. Gale,et al.  Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics , 2017, Oncotarget.

[4]  C. Hoffmann,et al.  CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis , 2016, Oncotarget.

[5]  Ye Chen,et al.  Tumor microenvironment: Sanctuary of the devil. , 2015, Cancer letters.

[6]  A. Tzankov,et al.  Role of the Tumor Microenvironment in Breast Cancer , 2015, Pathobiology.

[7]  D. Amadori,et al.  Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. , 2015, Journal of the National Cancer Institute.

[8]  S. Ishikawa,et al.  The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma , 2015, BMC Cancer.

[9]  C. Hamashima Current issues and future perspectives of gastric cancer screening. , 2014, World journal of gastroenterology.

[10]  Zongguang Zhou,et al.  Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital , 2014, Medical Oncology.

[11]  I. Shmulevich Large-scale molecular characterization and analysis of gastric cancer , 2014, Chinese journal of cancer.

[12]  Derek S. Chan,et al.  Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer , 2013, Proceedings of the National Academy of Sciences.

[13]  M. Junttila,et al.  Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.

[14]  Y. Qu,et al.  Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. , 2013, Cancer letters.

[15]  Yixuan Hou,et al.  Biological Characteristics and Genetic Heterogeneity between Carcinoma-Associated Fibroblasts and Their Paired Normal Fibroblasts in Human Breast Cancer , 2013, PloS one.

[16]  S. Koontongkaew The Tumor Microenvironment Contribution to Development, Growth, Invasion and Metastasis of Head and Neck Squamous Cell Carcinomas , 2013, Journal of Cancer.

[17]  Y. Kodera,et al.  Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry , 2012, Gastric Cancer.

[18]  Xiaomin Li,et al.  Metastasis of Head and Neck Squamous Cell Carcinoma , 2012 .

[19]  Pingbo Chen 陈平波,et al.  Breast cancer associated fibroblasts promote MCF-7 invasion in vitro by secretion of HGF , 2012, Journal of Huazhong University of Science and Technology [Medical Sciences].

[20]  E. Mekada,et al.  HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. , 2011, Cancer research.

[21]  Xi Chen,et al.  A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. , 2011, European journal of cancer.

[22]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[23]  W. Aulitzky,et al.  Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts , 2010, Molecular Cancer.

[24]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[25]  A. Friedl,et al.  Heterogeneity of Gene Expression in Stromal Fibroblasts of Human Breast Carcinomas and Normal Breast , 2009, Oncogene.

[26]  Graça Raposo,et al.  Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.

[27]  A. Kate Sasser,et al.  Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression , 2009, PloS one.

[28]  S. Kakar,et al.  Unique Methylation Pattern of Oncostatin M Receptor Gene in Cancers of Colorectum and Other Digestive Organs , 2009, Clinical Cancer Research.

[29]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[30]  W. Jonat,et al.  Heterogeneity of gene expression in stromal fibroblasts of breast carcinomas and normal breast. , 2009 .

[31]  F. Pépin,et al.  Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.

[32]  Douglas B. Evans,et al.  Cancer-associated stromal fibroblasts promote pancreatic tumor progression. , 2008, Cancer research.

[33]  R. Parton Faculty Opinions recommendation of Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. , 2007 .

[34]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[35]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[36]  Terry J. Smith,et al.  More Than Structural Cells, Fibroblasts Create and Orchestrate the Tumor Microenvironment , 2006, Immunological investigations.

[37]  J. Luk,et al.  Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas , 2005, Clinical Cancer Research.

[38]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[39]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[40]  Z. Werb,et al.  The fibroblastic coconspirator in cancer progression. , 2005, Cold Spring Harbor symposia on quantitative biology.

[41]  G. Woude,et al.  HGF/SF-Met signaling in tumor progression , 2005, Cell Research.

[42]  F. Balkwill Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[43]  A. Miyajima,et al.  Oncostatin M, a multifunctional cytokine. , 2003, Reviews of physiology, biochemistry and pharmacology.

[44]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[45]  C. Begley,et al.  The oncostatin M signalling pathway: reversing the neoplastic phenotype? , 1999, Molecular medicine today.

[46]  C. Begley,et al.  Oncostatin M induces the differentiation of breast cancer cells , 1998, International journal of cancer.

[47]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[48]  R. Weiskirchen,et al.  Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains. , 1993, Oncogene.

[49]  R. Tiwari,et al.  Who is (are) the author(s) , 1977 .